A comprehensive catalogue of somatic mutations from a human cancer genome

Erin Pleasance(Wellcome Sanger Institute), R. Keira Cheetham(Illumina (United Kingdom)), Philip J. Stephens(Wellcome Sanger Institute), David J. McBride(Wellcome Sanger Institute), Sean Humphray(Illumina (United Kingdom)), Chris Greenman(Wellcome Sanger Institute), Ignacio Varela(Wellcome Sanger Institute), Meng‐Lay Lin(Wellcome Sanger Institute), Gonzalo R. Ordóñez(Wellcome Sanger Institute), Graham R. Bignell(Wellcome Sanger Institute), Kai Ye(Leiden University Medical Center), Julie Alipaz(Illumina (United States)), Markus Bauer(Illumina (United Kingdom)), David Beare(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Richard J. Carter(Illumina (United Kingdom)), Lina Chen(Wellcome Sanger Institute), Anthony J. Cox(Illumina (United Kingdom)), Sarah Edkins(Wellcome Sanger Institute), Paula I. Kokko-Gonzales(Illumina (United Kingdom)), Niall Gormley(Illumina (United Kingdom)), Russell Grocock(Illumina (United Kingdom)), Christian Haudenschild(Illumina (United States)), Matthew M. Hims(Illumina (United Kingdom)), Terena James(Illumina (United Kingdom)), Mingming Jia(Wellcome Sanger Institute), Zoya Kingsbury(Illumina (United Kingdom)), Catherine Leroy(Wellcome Sanger Institute), John Marshall(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Laura Mudie(Wellcome Sanger Institute), Zemin Ning(Wellcome Sanger Institute), Tom Royce(Illumina (United States)), Ole Schulz-Trieglaff(Illumina (United Kingdom)), Anastassia Spiridou(Illumina (United Kingdom)), Lucy Stebbings(Wellcome Sanger Institute), Lukasz Szajkowski(Illumina (United Kingdom)), Jon W. Teague(Wellcome Sanger Institute), David Williamson(Illumina (United States)), Lynda Chin(Dana-Farber Cancer Institute), Mark T. Ross(Illumina (United Kingdom)), Peter J. Campbell(Wellcome Sanger Institute), David Bentley(Illumina (United Kingdom)), P. Andrew Futreal(Wellcome Sanger Institute), Michael R. Stratton(Wellcome Sanger Institute)
Nature
December 16, 2009
Cited by 1,725Open Access
Full Text

Abstract

All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic. The two cancer genome sequences presented in this issue demonstrate how next-generation sequencing technologies can inform us about mutational processes, repair pathways and gene networks associated with cancer development. First, the genome of a cell line derived from a bone marrow metastasis in a patient who had small-cell lung cancer. This cancer is typical of the type induced by smoking, and the sequence contains mutation signatures characteristic of some of the more than 60 carcinogens present in tobacco smoke. The second paper compares the whole genome sequence of a melanoma cell line to a lymphoblastoid cell line from the same individual. This, the first complete mutational analysis of a solid tumour, reveals a dominant mutational signature reflecting DNA damage due to exposure to ultraviolet light. Here, the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person are sequenced, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The data provide insight into the causes of tumour formation and the development of the cancer genome, with the dominant mutational signature reflecting DNA damage due to ultraviolet light exposure.


Related Papers

No related papers found

Powered by citation graph analysis